Axo Longevity offers a comprehensive health testing service that analyzes 100+ biomarkers across 36+ health areas to reveal underlying cardiovascular, metabolic, hormonal, and inflammatory changes before symptoms appear. Customers receive a personalized action plan within 3–4 weeks and can track measurable progress through a network of 1,450+ testing locations across Europe. The service starts at €490 per year, with all tests processed through CE-IVD certified labs.
Funding
Funding not disclosed
Founders
Product
Problem
Most people assess their health based on how they feel, but the majority of cardiovascular, metabolic, hormonal, and inflammatory changes begin silently before any symptoms emerge. Standard blood tests check only a handful of markers and stop there, leaving critical health risks undetected until they become more serious.
Solution
Axo Longevity provides a comprehensive health testing platform that analyzes 100+ biomarkers across 36+ health areas, far exceeding what standard check-ups typically cover. Customers visit one of 1,450+ testing locations across Europe, and within 3–4 weeks receive a personalized action plan that translates their results into specific lifestyle and medical recommendations. The service covers energy, stress, sleep, sexual performance, heart health, bone health, and immunity, helping users understand exactly what to change to feel better and perform better. Progress is tracked over time through repeat testing, allowing customers to see measurable improvements and adjust their health strategies accordingly.
Target Audience
Primary customers are health-conscious adults aged 30–65 who want proactive, data-driven insights into their long-term health, including athletes, busy professionals, and individuals with family histories of cardiovascular or metabolic conditions.
Features
- 100+ lab tests covering 36+ health areas including energy, stress, sleep, sexual performance, heart health, bone health, and immunity
- Personalized action plan delivered within 3–4 weeks with specific recommendations based on individual biomarker results
- Network of 1,450+ testing locations across the UK, Spain, Germany, the Netherlands, and Ireland
- CE-IVD certified labs ensuring clinical-grade accuracy and reliability
- GDPR-compliant data protection with SSL and Stripe encrypted payments
- Annual subscription model at €490/year (≈ €41/month) with repeat testing for progress tracking